456
Views
30
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)

, , , , , , , & show all
Pages 252-254 | Received 20 Feb 2012, Accepted 04 Jul 2012, Published online: 08 Sep 2012

References

  • Richter M. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 1928;6:285–299.
  • Lortholary P, Ripault M, Boiron M. [Richter's syndrome]. Nouv Rev Fr Hematol 1964;72:456–457.
  • Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer 1978;41:422–427.
  • Foucar K, Rydell RE. Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980;46:11C8–134.
  • Robertson LE, Pugh W, O’Brien S, . Richter's syndrome: a report on 39 patients. J Clin Oncol 1993;11:1985–1989.
  • Rai KR, Peterson BL, Appelbaum FR, . Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000;343:1750–1757.
  • Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol 2004;5:215–223.
  • Tsimberidou AM, Wen W, McLaughlin P, . Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009;27:904–910.
  • Morrison VA, Rai KR, Peterson BL, . Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002;20:3878–3884.
  • Rai K, Peterson BL, Appelbaum FR, . Long-term survival analysis of the North American intergroup study C9011 comparing fludarabine (F) and chlorambucil © in previously untreated patients with chronic lymphocytic leukemia (CLL). Blood 2009;114(Suppl. 1): Abstract 536.
  • Jelic S, Jovanovic V, Milanovic N, . Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia. Neoplasia 1997;44:63–68.
  • Mauro FR, Foa R, Giannarelli D, . Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 1999;94:448–454.
  • Rossi D, Cerri M, Capello D, . Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2008;142:202–215.
  • Keating MJ, O’Brien S, Lerner S, . Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998;92:1165–1171.
  • Thornton PD, Bellas C, Santon A, . Richter's transformation of chronic lymphocytic leukemia: the possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leuk Res 2005;29:389–395.
  • Deambrogi C, Cresta S, Cerri M, . 14q32 translocations and risk of Richter transformation in chronic lymphocytic leukaemia. Br J Haematol 2008;144:131–133.
  • Aydin S, Rossi D, Bergui L, . CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood 2008;111:5646–5653.
  • Rossi D, Spina V, Cerri M, . Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009;15:4415–4422.
  • Maddocks-Christianson K, Slager SL, Zent CS, . Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukemia. Br J Haematol 2007;139:398–404.
  • Leleu X, Soumerai J, Rocarro A, . Increased incidence of transformation and myelodysplasis/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs. J Clin Oncol 2008;27:250–255.
  • Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology 2004;9:387–400.
  • Robak T, Blonski JZ, Gora-Tybor J, . Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer 2004;40:383–389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.